BioCardia, Inc. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/242dd4bf-8b65-45be-9250-0e0fab50fdf3/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-009587 |
| FY 2024 | $58.0k | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-009397 |
| FY 2023 | $477.0k | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-009587 |
| FY 2022 | $1.4M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-008312 |
| FY 2021 | $1.0M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-007544 |
| FY 2020 | $145.0k | 2020-01-01 – 2020-12-31 | evidence 0001437749-21-007543 |
| FY 2019 | $710.0k | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-007405 |
| FY 2018 | $625.0k | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-006300 |
| FY 2017 | $479.0k | 2017-01-01 – 2017-12-31 | evidence 0001437749-19-006300 |
| FY 2016 | $576.0k | 2016-01-01 – 2016-12-31 | evidence 0001437749-19-006300 |
| FY 2015 | $860.0k | 2015-01-01 – 2015-12-31 | evidence 0001437749-17-005643 |
| FY 2011 | $12.0k | 2011-01-01 – 2011-12-31 | evidence 0001136261-12-000180 |
| FY 2010 | $0 | 2010-01-01 – 2010-12-31 | evidence 0001136261-12-000180 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).